These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15471301)

  • 41. Human immunodeficiency virus infection in elderly patients.
    Butt AA; Dascomb KK; DeSalvo KB; Bazzano L; Kissinger PJ; Szerlip HM
    South Med J; 2001 Apr; 94(4):397-400. PubMed ID: 11332905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death.
    Hicks CB
    J Watch AIDS Clin Care; 2010 Jan; 22(1):4. PubMed ID: 20617576
    [No Abstract]   [Full Text] [Related]  

  • 43. [Survival rate of HIV infected patients depends on CD4 count at therapy initiation].
    Blasko M
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1519. PubMed ID: 12899164
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results].
    Lewden C; Chêne G; Morlat P; Raffi F; Dabis F; Leport C;
    Med Sci (Paris); 2008 Oct; 24(10):804-6. PubMed ID: 18950574
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiretroviral therapy: select lessons from recent studies.
    Saag MS
    Top HIV Med; 2003; 11(5):164-8. PubMed ID: 14555804
    [No Abstract]   [Full Text] [Related]  

  • 46. [Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology].
    Moreno S; Arrizabalaga J; Gatell JM; Clotet B; Aguirrebengoa K; Antela A; Iribarren JA; Laguna F; Miró JM; Ocaña I; Rubio R; Viciana P; Podzamczer D
    Med Clin (Barc); 1998 Jan; 110(3):109-16. PubMed ID: 9580197
    [No Abstract]   [Full Text] [Related]  

  • 47. High rate of misclassification of treatment failure based on WHO immunological criteria.
    Castelnuovo B; Kiragga A; Schaefer P; Kambugu A; Manabe Y
    AIDS; 2009 Jun; 23(10):1295-6; author reply 1296. PubMed ID: 19509481
    [No Abstract]   [Full Text] [Related]  

  • 48. Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care?
    van Griensven J; Sopheak T; Aseffa Y; Van Damme W; Lynen L
    Trans R Soc Trop Med Hyg; 2010 Oct; 104(10):690-2; author reply 692-3. PubMed ID: 20800253
    [No Abstract]   [Full Text] [Related]  

  • 49. When do HIV-infected persons start with antiretroviral therapy? A retrospective analysis of patients' monitoring and treatment status in general practice, as compared with the 1991 Dutch HIV treatment guidelines.
    Reedijk M; Wigersma L; Mohrs J
    Fam Pract; 1998 Dec; 15(6):525-8. PubMed ID: 10078791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival benefit from non-highly active antiretroviral therapy in a resource-constrained setting.
    Pathipvanich P; Ariyoshi K; Rojanawiwat A; Wongchoosie S; Yingseree P; Yoshiike K; Warachit P; Sawanpanyalert P
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):157-60. PubMed ID: 12571525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. All patients with HIV should get access to drug treatments regardless of CD4 count, says WHO.
    Gulland A
    BMJ; 2015 Sep; 351():h5239. PubMed ID: 26427899
    [No Abstract]   [Full Text] [Related]  

  • 52. A normal life expectancy, despite HIV infection?
    Hill A; Pozniak A
    AIDS; 2010 Jun; 24(10):1583-4. PubMed ID: 20479635
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimal time to initiate anti-HIV therapy: clinical decisions without definitive data.
    Volberding P
    Infect Agents Dis; 1992 Jun; 1(3):163-6. PubMed ID: 1365541
    [No Abstract]   [Full Text] [Related]  

  • 54. Course of Disease and Clinical Outcome of Infective Endocarditis in HIV-infected Individuals: A Systematic Review and Meta-analysis.
    Bos J; Antonides CFJ; Barth RE; Klipstein-Grobusch K; Meel R; Vos AG
    AIDS Rev; 2020 Dec; 22(4):183-194. PubMed ID: 33401286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commentary: can mortality rates among adult antiretroviral therapy patients in Europe reach levels similar to those experienced in the general population?
    Auld AF; Ellerbrock TV
    Int J Epidemiol; 2012 Apr; 41(2):445-7. PubMed ID: 22395023
    [No Abstract]   [Full Text] [Related]  

  • 56. Research. Smoking linked to higher health risks, mortality rate for individuals with HIV.
    AIDS Policy Law; 2010 Oct; 25(11):1. PubMed ID: 21049596
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiretroviral therapy in adults.
    Wise B
    J Am Acad Nurse Pract; 1996 Jul; 8(7):329-41. PubMed ID: 9281977
    [No Abstract]   [Full Text] [Related]  

  • 58. Wasting syndrome in HIV/AIDS patients. A guide to prevention and management.
    Woolard S
    Adv Nurse Pract; 2001 Sep; 9(9):42-6; quiz 47-8. PubMed ID: 12420481
    [No Abstract]   [Full Text] [Related]  

  • 59. HIV treatments: a history of scientific advance.
    Shernoff M; Smith RA
    Body Posit; 2001 Jul; 14(7):16-21. PubMed ID: 11548436
    [No Abstract]   [Full Text] [Related]  

  • 60. Measuring the effect of clinical guidelines on patient outcomes.
    Marshall DA; Simpson KN; Norton EC; Biddle AK; Youle M
    Int J Technol Assess Health Care; 2000; 16(4):1013-23. PubMed ID: 11155825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.